Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05698628

Comparison of Preemptive Versus Conventional Distal Perfusion in Peripheral VA-ECMO

Conditions: Extracorporeal Membrane Oxygenation Complication

Sex: All
Ages: 19 Years – N/A
Phase: NA
Enrollment: 400
Sponsor: Min-Seok Kim

Location: Korea, Republic of

Summary

Peripheral VA-ECMO is widely used in refractory cardiogenic shock patients as a salvage therapy. In most cases, the femoral artery and vein are used for the vascular approach. Large cannulas are usually used for proper oxygenation, which may cause peripheral limb ischemia. Distal perfusion catheterization (DPC) at the ipsilateral arterial cannula site is recommended to prevent distal limb ischemia. However, there is no consensus on the proper timing of DPC and additional invasive procedures may cause complications during VA-ECMO support. In this analysis, the investigators compare the clinical outcomes of distal limb ischemia complications between the conventional DPC group (DPC at the time of limb ischemia sign) and the preemptive DPC group (DPC at the time of VA-ECMO application).

Eligibility Criteria

Inclusion Criteria:Age ≥19 years oldRefractory cardiogenic shock with peripheral VA-ECMOInformed consentExclusion Criteria:Unwilling or unable to obtain informed consent from the participant or substitute decision-makerPatients who are currently pregnant, postpartum period within 30 days or are breast-feedingVA-ECMO application for causes other than cardiogenic shockSevere coagulopathyIrreversible limb ischemia requiring interventional procedures or surgery at the time of VA-ECMO (previously diagnosed ASO(atherosclerosis obliterans) patients)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05698628). StuddyBuddy aggregates publicly available trial information.